Wave Life Sciences (WVE) Net Income towards Common Stockholders: 2015-2025
Historic Net Income towards Common Stockholders for Wave Life Sciences (WVE) over the last 11 years, with Sep 2025 value amounting to -$53.9 million.
- Wave Life Sciences' Net Income towards Common Stockholders rose 12.83% to -$53.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$121.9 million, marking a year-over-year increase of 14.45%. This contributed to the annual value of -$97.0 million for FY2024, which is 68.67% down from last year.
- Latest data reveals that Wave Life Sciences reported Net Income towards Common Stockholders of -$53.9 million as of Q3 2025, which was down 6.70% from -$50.5 million recorded in Q2 2025.
- In the past 5 years, Wave Life Sciences' Net Income towards Common Stockholders registered a high of $29.3 million during Q4 2024, and its lowest value of -$61.8 million during Q3 2024.
- In the last 3 years, Wave Life Sciences' Net Income towards Common Stockholders had a median value of -$31.6 million in 2024 and averaged -$27.8 million.
- The largest annual percentage gain for Wave Life Sciences' Net Income towards Common Stockholders in the last 5 years was 279.70% (2024), contrasted with its biggest fall of 949.21% (2024).
- Quarterly analysis of 5 years shows Wave Life Sciences' Net Income towards Common Stockholders stood at -$34.8 million in 2021, then decreased by 25.65% to -$43.7 million in 2022, then skyrocketed by 62.76% to -$16.3 million in 2023, then spiked by 279.70% to $29.3 million in 2024, then rose by 12.83% to -$53.9 million in 2025.
- Its Net Income towards Common Stockholders was -$53.9 million in Q3 2025, compared to -$50.5 million in Q2 2025 and -$46.9 million in Q1 2025.